Sort
25,944 grants matching “neurodegeneration”
Longitudinal multi-modality imaging in non-fluent/agrammatic primary progressive aphasia
$699,403Jennifer Louise Whitwell · Mayo Clinic Rochester · R01 · FY2023 · DC
Diffusion and Functional MRI Monitoring of Therapy Response in Alzheimerâs Disease Mouse Model
$699,324Jens H Jensen · Medical University Of South Carolina · R01 · FY2023 · AG
Mesoscopic Biomarkers of Neurodegeneration and Inflammation with Diffusion MRI
$699,188Els Fieremans · New York University School Of Medicine · R01 · FY2019 · NS
Development of Spleen Tyrosine Kinase (SYK) negative allosteric modifiers for therapeutic intervention in Alzheimer's disease.
$699,018Michael Mullan · Archer Pharmaceuticals, Inc. · R42 · FY2021 · AG
Nitric Oxide-Soluble Guanylate Cyclase Pathway as a Target for Male Bladder Outlet Obstruction and Lower Urinary Tract Symptoms in Aging
$698,978Anthony John Kanai · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · DK
Nitric Oxide-Soluble Guanylate Cyclase Pathway as a Target for Male Bladder Outlet Obstruction and Lower Urinary Tract Symptoms in Aging
$698,978Anthony John Kanai · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DK
Study to establish safety, tolerability and feasibility of LM11A-31 as a neuroprotective agent in aging people living with HIV and neurocognitive impairment on antiretroviral therapy
$698,919Rick B Meeker · Univ Of North Carolina Chapel Hill · R01 · FY2023 · AG
TFEB-mediated lysosome-to-nucleus signaling in aging and lifespan regulation
$698,862Marco Sardiello · Baylor College Of Medicine · P01 · FY2025 · AG
Chemogenetic Neurovascular Oxidative Stress: Neurodegeneration and Cardiac Remodeling
$698,827Thomas Michel · Brigham And Women'S Hospital · R01 · FY2025 · NS
Role of Neurotrophins in the Development of the Mammalian Nervous System
$698,761Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Mechanisms of Prion Spread and Neuronal Toxicity
$698,643Christina Sigurdson · University Of California, San Diego · R37 · FY2024 · NS
Leucine as a Probe of Kynurenine-Induced Glutamate and Neural Circuit Dysfunction in Midlife Depression
$698,108Ebrahim Haroon · Emory University · R01 · FY2024 · MH
Dissect the mechanisms of selective regional vulnerability in Lewy Body Dementias via comparative snRNA-seq analysis
$698,105Guoyan Zhao · Washington University · R01 · FY2022 · NS
Pancreatic proteostasis connects sleep disruption to Alzheimers Disease
$697,974Nirinjini N Naidoo · University Of Pennsylvania · R56 · FY2019 · AG
Alternative vacuolar targeting mechanisms in yeast
$697,966Daniel J. Klionsky · University Of Michigan At Ann Arbor · R01 · FY2009 · GM
Regulation of CHCHD6 in Alzheimer's disease
$697,772Xin Qi · Case Western Reserve University · R01 · FY2025 · AG
A microphysiologic multicellular organ-on-chip to inform clinical trials in FTD/ALS
$697,574Clive Niels Svendsen · Cedars-Sinai Medical Center · UH3 · FY2024 · TR
AAV capsid engineering for enhancing gene transfer
$697,526Mark A Kay · Stanford University · R01 · FY2021 · AI
AAV capsid engineering for enhancing gene transfer
$697,416Mark A Kay · Stanford University · R01 · FY2022 · AI
The role of the Cockayne syndrome protein
$697,124Vilhelm A Bohr · National Institute On Aging · ZIA · FY2019 · AG
Biological 'Living Electrodes' Using Tissue Engineered Axonal Tracts to Probe and Modulate the Nervous System
$697,112Daniel Kacy Cullen · University Of Pennsylvania · U01 · FY2015 · NS
Identification of small molecules for neurological complications of HIV and substance abuse comorbidity
$696,944Pietro P Sanna · Scripps Research Institute, The · R01 · FY2018 · DA
Impact of the gut microbiome on B cell-mediated neuroinflammation in cerebral amyloid angiopathy
$696,896Juneyoung Lee · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · AG
AAV capsid engineering for enhancing gene transfer
$696,800Mark A Kay · Stanford University · R01 · FY2023 · AI
Improving the sensitivity and specificity of MRI-based biomarkers in Alzheimer's disease
$696,709Paul A. Yushkevich · University Of Pennsylvania · R01 · FY2024 · AG